상세 보기
자료 필터
자료유형
발행연도
1996 ~ 2026
1996 2026
키워드
언어
전체 280건 중 31번부터 40번까지의 결과를 표시합니다.
2020
Conference
Efficacy and safety of lazertinib 240 mg as the clinical dose in patients with EGFR T790M mutant NSCLC: Data from a phase I/II study.
- Lee, Ki Hyeong ;
- Ahn, Myung-Ju ;
- Han, Ji-Youn ;
- Kim, Sang-We ;
- Cho, Eun Kyung ;
- ... Lee, Jong-Seok ;
- ... Shin, Sang Won ;
- 외 13명
- 2020-05-20
- 미국
Conference
ctDNA resistance landscape of lazertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI).
- Han, Ji-Youn ;
- Ahn, Myung-Ju ;
- Kim, Sang-We ;
- Lee, Ki Hyeong ;
- Cho, Eun Kyung ;
- ... Lee, Jong-Seok ;
- ... Shin, Sang Won ;
- 외 13명
- 2020-05-20
- 미국
Conference
Intracranial anti-tumor activity of lazertinib in patients with advanced NSCLC who progressed after prior EGFR TKI therapy: Data from a phase I/II study.
- Kim, Sang-We ;
- Ahn, Myung-Ju ;
- Han, Ji-Youn ;
- Lee, Ki Hyeong ;
- Cho, Eun Kyung ;
- ... Lee, Jong-Seok ;
- ... Shin, Sang Won ;
- 외 13명
- 2020-05-20
- 미국
Article
Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer
- 2020-02
- New England Journal of Medicine
- Massachusetts Medical Society
Conference
Breast cancer genomic landscape according to germline BRCA1/2 pathogenicity
- Kim, Ju Won ;
- Choi, Jung Yoon ;
- Lee, Soo Hyeon ;
- Chang, Won Jin ;
- Bae, Soo Youn ;
- ... Choi, Yoon Ji ;
- ... Jung, Seung Pil ;
- ... Cho, Kyu Ran ;
- ... Shin, Sang Won ;
- ... Park, Kyong Hwa ;
- 외 1명
- 2020-02
- 미국
2019